Recent advances in PLGA micro/nanoparticle delivery systems as novel therapeutic approach for drug-resistant tuberculosis

Tuberculosis is a severe infectious disease caused by Mycobacterium tuberculosis and is a significant public health concern globally. The World Health Organization (WHO) recommends a combination regimen of several drugs, such as rifampicin (RIF), isoniazid (INH), pyrazinamide (PZA), and ethambutol (...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Liqun, Shen, Shu, Liu, Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355142/
https://www.ncbi.nlm.nih.gov/pubmed/35935487
http://dx.doi.org/10.3389/fbioe.2022.941077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355142/
https://www.ncbi.nlm.nih.gov/pubmed/35935487
http://dx.doi.org/10.3389/fbioe.2022.941077

Ejemplares similares